< Back to catalogue
Rivaroxaban/Pharmazac
July 28, 2026Sugammadex/Pharmazac
July 28, 2026PHARMAZAC
Sitagliptin+Metformin/Pharmazac
Sitagliptin/Metformin | Hypoglycemic | Primary Care
| SITAGLIPTIN+METFORMIN/PHARMAZAC FCTAB(50+850) |
| SITAGLIPTIN+METFORMIN/PHARMAZAC FCTAB(50+1000) |
| SITAGLIPTIN+METFORMIN/PHARMAZAC FCTAB(50+850) |
| SITAGLIPTIN+METFORMIN/PHARMAZAC FCTAB(50+1000) |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
